# Placebo Controlled, Dose Escalation Study in Subjects With Type 2 Diabetes Mellitus Being Treated With Sulfonylurea

> **NCT00455598** · PHASE2 · COMPLETED · sponsor: **Ionis Pharmaceuticals, Inc.** · enrollment: 88 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** ISIS 113715

## Key facts

- **NCT ID:** NCT00455598
- **Lead sponsor:** Ionis Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2009-03
- **Final completion:** 2009-05
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2009-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00455598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00455598, "Placebo Controlled, Dose Escalation Study in Subjects With Type 2 Diabetes Mellitus Being Treated With Sulfonylurea". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00455598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*